Article

Sclerotherapy for hydroceles.

Department of Urology, Medical University of Southern Africa, Pretoria.
The Journal of Urology (Impact Factor: 3.75). 06/1990; 143(5):940-3.
Source: PubMed

ABSTRACT Sclerotherapy with 3% sodium tetradecyl sulfate and 3.5% rolitetracycline on an outpatient basis was applied to 55 hydroceles. The over-all cure rate was 96% with an average followup of 13 months. Of the patients 64% were cured after only 1 sclerosant instillation. A post-sclerotherapy operation was necessary in 4% of the patients. Pain of a significant degree occurred after sclerotherapy in only 29% of the patients. Sclerotherapy appears to be an effective, economical and safe form of outpatient therapy for hydroceles.

1 Bookmark
 · 
226 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: A hydrocele is an abnormal collection of serous fluid in the space between the parietal and visceral layers of the tunica vaginalis. Hydrocele is the most common cause of painless scrotal swelling which affects about 1% of men. Generally, adult hydroceles are idiopathic in origin; however, inguinal surgery, varicocelectomy, infection, trauma and a patent processus vaginalis are each associated with the subsequent development of a hydrocele. Surgical removal of hydroceles is the gold standard of care. However, multiple cases have reported high success rates (ranging from 85% to 96%) using a combination of aspiration and sclerotherapy. We present a case of a patient with recurring complex hydrocele and effective treatment utilizing a combination of thrombolytic therapy, catheter drainage and subsequent alcohol ablation.
    05/2014; 8(5-6):E445-8.
  • [Show abstract] [Hide abstract]
    ABSTRACT: The present study was carried out with an aim to perform a prospective study to establish the role of sodium tetradecyl sulfate (3 %) (STDS) as a safe and effective sclerosant in the management of primary hydrocele. Sclerotherapy was performed with 3 % STDS on an outdoor basis. The amount of sclerosant injected depended on the amount of fluid drained. All patients were given prophylactic antibiotics. Patients were clinically reassessed at 1 week, 1 month, 3 months, and 6 months and earlier if complications occur. The data were analyzed using Statistical Package for Social Sciences Version 15.0. The data have been represented as frequencies and percentages. Chi-square test was used to compare the data. A total of 57 patients with primary vaginal hydrocele gave consent for being enrolled in the study. The age of patients ranged from 18 to 65 years with a mean age of 35.72 ± 13.18 years. The success rate at the end of the study was observed to be 84.2 %. As regards patient satisfaction, in present study, in a limited time period of follow up, all the patients who had a successful procedure were satisfied. Overall, sclerotherapy was observed to be a relatively cost-effective (including both direct and indirect costs) procedure with low complications, high satisfaction, and a high success rate within the limited period of follow-up.
    Indian Journal of Surgery · 0.27 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Is aspiration and sclerosing of hydrocele testis (HT) an effective treatment? Men with symptomatic HT were included in this first prospective double-blind randomized study with aethoxysclerol and placebo. Patients were randomized to either active treatment or placebo at first treatment. Using various doses of Aetoxysklerol dependent on HT size (<100 ml, 100 to 200ml and> 200 ml), the patients were treated with 1 ml, 3 ml or 4 ml Aethoxy-sklerol after aspiration. Patients with recurrence at the 5-week follow-up all received active treatment. A total of 77 patients were included in the study. In Group A (active), there were 36 patients, median age 63 years (34-92) and in B 41 patients' median age 59 years (26-82). The median follow-up time was 72 months. A significant difference between the two groups was observed after both the first and the second treatment. Recurrence after the first treatment was seen in 16 (44%) patients from group A and in 32 (78%) patients in group B (p <0.05); recurrence after retreatment with active drug in both groups was seen in 4 (25%) patients in group A and in 14 (44%) in the former placebo group (p <0.05). The overall success rate of treatment in the active group was 89%. There was no difference between the two groups in terms of volume of fluid aspirated, symptoms or complications. This long-term efficacy randomized study with placebo showed that Aethoxysklerol is effective for treatment of HT with low recurrence rate.
    The Journal of urology 11/2013; · 3.75 Impact Factor